Risk factors of recurrence in patients with cancer-associated venous thromboembolism

      The following other authors from the COMMAND VTE Registry Investigators participated the study: Syunsuke Saga, MDa; Kazushige Kadota, MDb; Toru Takase, MDc; Seiichi Hiramori, MDd; Kitae Kim, MDe; Maki Oi, MDf; Masaharu Akao, MDg; Yohei Kobayashi, MDh; Mamoru Toyofuku, MDi; Takao Kato, MDj; Koh Ono, MDj.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kearon C
        • Akl EA
        • Ornelas J
        • Blaivas A
        • Jimenez D
        • Bounameaux H
        • et al.
        Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.
        Chest. 2016; 149: 315-352
        • Konstantinides SV
        • Meyer G
        • Becattini C
        • Bueno H
        • Geersing G-J
        • Harjola V-P
        • et al.
        2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).
        Eur Heart J. 2020; 41: 543-603
        • Key NS
        • Khorana AA
        • Kuderer NM
        • Bohlke K
        • Lee AYY
        • Arcelus JI
        • et al.
        Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.
        JCO. 2019; 38: 496-520
        • Prandoni P
        • Lensing AWA
        • Piccioli A
        • Bernardi E
        • Simioni P
        • Girolami B
        • et al.
        Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.
        Blood. 2002; 100: 3484-3488
        • Yamashita Y
        • Morimoto T
        • Amano H
        • Takase T
        • Hiramori S
        • Kim K
        • et al.
        Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
        Circ J. 2018; 82: 1262-1270
        • Khorana AA
        • Kuderer NM
        • Culakova E
        • Lyman GH
        • Francis CW.
        Development and validation of a predictive model for chemotherapy-associated thrombosis.
        Blood. 2008; 111: 4902-4907
        • Hansson PO
        • Sörbo J
        • Eriksson H.
        Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.
        Arch Intern Med. 2000; 160: 769-774
        • Louzada ML
        • Carrier M
        • Lazo-Langner A
        • Dao V
        • Kovacs MJ
        • Ramsay TO
        • et al.
        Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
        Circulation. 2012; 126: 448-454
        • Astruc N
        • Ianotto J-C
        • Metges J-P
        • Lacut K
        • Delluc A.
        External validation of the modified Ottawa score for risk stratification of recurrent cancer-associated thrombosis.
        Eur J Intern Med. 2016; 36: e11-e12
        • Nishimoto Y
        • Yamashita Y
        • Morimoto T
        • Saga S
        • Amano H
        • Takase T
        • et al.
        Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
        Thromb Res. 2020; 191: 66-75